Industry Focus

Competitors make headway against Teva Pharmaceutical's top-seller, and Biogen's hemophilia drugs become Bioverativ. Here's what you should know.

Direct download: 20170201_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST